These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24853588)

  • 1. Decreased c-rel activation contributes to aberrant interleukin-2 expression in CD4(+)T cells of aged rats.
    Gong Z; Liu T; Wan Y; Hang Z; Tong X; Zhang B; Yang H; Zhang X; Zhang L; Jin G
    Mol Immunol; 2014 Sep; 61(1):1-6. PubMed ID: 24853588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
    Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
    Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.
    Chen G; Hardy K; Bunting K; Daley S; Ma L; Shannon MF
    J Immunol; 2010 Aug; 185(4):2350-9. PubMed ID: 20639489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human amniotic epithelial cells inhibit CD4+ T cell activation in acute kidney injury patients by influencing the miR-101-c-Rel-IL-2 pathway.
    Liu J; Hua R; Gong Z; Shang B; Huang Y; Guo L; Liu T; Xue J
    Mol Immunol; 2017 Jan; 81():76-84. PubMed ID: 27898347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Rel is required for chromatin remodeling across the IL-2 gene promoter.
    Rao S; Gerondakis S; Woltring D; Shannon MF
    J Immunol; 2003 Apr; 170(7):3724-31. PubMed ID: 12646638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR/CD28-stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation.
    Nolz JC; Fernandez-Zapico ME; Billadeau DD
    J Immunol; 2007 Jul; 179(2):1104-12. PubMed ID: 17617603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Th17 differentiation in aged mice is significantly associated with high IL-1β level and low IL-2 expression.
    Lim MA; Lee J; Park JS; Jhun JY; Moon YM; Cho ML; Kim HY
    Exp Gerontol; 2014 Jan; 49():55-62. PubMed ID: 24140620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic regulation of Il2 transcription in CD4+ T cells: roles for TNF-alpha receptor signaling and chromatin structure.
    McKarns SC; Schwartz RH
    J Immunol; 2008 Jul; 181(2):1272-81. PubMed ID: 18606681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor-4 activates IL-2 and IL-4 promoters in cooperation with c-Rel.
    Shindo H; Yasui K; Yamamoto K; Honma K; Yui K; Kohno T; Ma Y; Chua KJ; Kubo Y; Aihara H; Ito T; Nagayasu T; Matsuyama T; Hayashi H
    Cytokine; 2011 Dec; 56(3):564-72. PubMed ID: 21890374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients.
    Zhao M; Liu Q; Liang G; Wang L; Luo S; Tang Q; Zhao H; Su Y; Yung S; Chan TM; Lu Q
    J Autoimmun; 2013 Mar; 41():152-60. PubMed ID: 23340290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells.
    Visekruna A; Huber M; Hellhund A; Bothur E; Reinhard K; Bollig N; Schmidt N; Joeris T; Lohoff M; Steinhoff U
    Eur J Immunol; 2010 Mar; 40(3):671-6. PubMed ID: 20049877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related decline in activation of JNK by TCR- and CD28-mediated signals in murine T-lymphocytes.
    Kirk CJ; Freilich AM; Miller RA
    Cell Immunol; 1999 Nov; 197(2):75-82. PubMed ID: 10607424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine production by T lymphocytes from young and aged mice.
    Engwerda CR; Fox BS; Handwerger BS
    J Immunol; 1996 May; 156(10):3621-30. PubMed ID: 8621895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rottlerin inhibits human T cell responses.
    Springael C; Thomas S; Rahmouni S; Vandamme A; Goldman M; Willems F; Vosters O
    Biochem Pharmacol; 2007 Feb; 73(4):515-25. PubMed ID: 17141738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15.
    Lee CC; Lin SJ; Cheng PJ; Kuo ML
    Pediatr Allergy Immunol; 2009 Nov; 20(7):624-32. PubMed ID: 19302176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct pattern of IL-2 and IFN-gamma gene expression in CD4 and CD8 T cells: cytofluorometric analysis at a single cell level using non-radioactive probes.
    Morvan PY; Picot C; Dejour R; Genetet B; Genetet N
    Cell Mol Biol (Noisy-le-grand); 1995 Nov; 41(7):945-57. PubMed ID: 8595373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional control of IL-2 and IL-4 in T cells of young and old mice.
    Albright JW; Zúñiga-Pflücker JC; Albright JF
    Cell Immunol; 1995 Sep; 164(2):170-5. PubMed ID: 7656324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.